As a team, we have over 40 years of combined experience executing disruptive technology-related investments. This translates to more than a billion in capital being put to work across 30 direct investments, 40 fund investments, and 500-plus portfolio companies. Each of us contributes distinguished technology investing experience spanning an array of industries and markets. What excites us most about this work? Investing at the nexus of transformational technologies, exploding markets and where we can tap our extensive C-level connections at Fortune 200 companies.
Chief Financial Officer
Director, Communications
Venture Advisor
Investor - LRG Ventures,
Managing Director, IP and Research, Emory
Venture Advisor
Chair –The Emory Institute for Drug Development
Chair - Drug Innovation Ventures at Emory
Venture Advisor
Investor, LRG Ventures
Chief of Staff and Director of Financial Operations,
Liotta Research Group.
Venture Advisor
Professor of Surgery, Medicine and Pediatrics, UCSF
Science Board at FDA, Rosenman Inst. Founding Fellow, Medical Director, Kidney, Pancreas Transplant Program, UCSF
Venture Advisor
MD MGH/HMS, MLK Scholar, Fmr. Communications Fellow CDC, Gold Congressional Award Winner
Venture Advisor
“Fortune 1000 companies in the top quartile of ethnic diversity among their senior management outperformed their peers in EBITDA margin by 35%.”
– McKinsey & Company 2017 Study “Delivering Through Diversity”
We're capitalizing on this reality.